SRC and Nephropathy: Given the fact that MMP-2 and MMP-9 inhibitors significantly reduced the severity of renal tubule damage and suppressed the development of AKI after ischemia-reperfusion [44], we propose that Src may also aid in reducing epithelial and endothelial permeability and subsequent kidney damage by attenuating activity of these two proteinases.